Skip to main content
Log in

Antibiotic prophylaxis in recurrent erysipelas

Antibiotikaprophylaxe bei rezidivierendem Erysipel

  • Brief Communication
  • Published:
Infection Aims and scope Submit manuscript

Summary

Recurrences of erysipelas are especially prevalent in patients suffering from local impairment of circulation and intervention might thus be of benefit. Therefore a prospective, randomized, open study was undertaken to evaluate whether daily antibiotic prophylaxis would reduce the risk of recurrence. Patients with venous insufficiency or lymphatic congestion who had suffered two or more episodes of erysipelas during the previous 3 years and were admitted to the Infectious Disease Department at Roslagstull Hospital, Stockholm, Sweden, between November 1988 and November 1991 were included. Fourty patients, 20 on prophylaxis and 20 controls were followed according to a life table analysis during a median time of 15 months. Phenoxymethylpenicillin was prescribed as daily prophylaxis (while erythromycin was given to patients allergic to penicillin). Recurrences of erysipelas appeared to be reduced by daily antibiotic prophylaxis but the effect was not dramatic (p=0.06). Only in patients with a high recurrence rate continuous antibiotic prophylaxis against erysipelas is indicated.

Zusammenfassung

Rezidivierende Erysipele sind besonders häufig bei Patienten mit Durchblutungsstörungen. Aus diesem Grund könnte es sinnvoll sein, Gegenmaßnahmen zu ergreifen. Die Frage einer Reduktion des Rezidivrisikos wurde im Rahmen einer offenen, randomisierten Studie zur täglichen Antibiotikaprophylaxe geprüft. Patienten mit venöser Insuffizienz oder Lymphstauung, bei denen in den letzten drei Jahren mehr als drei Episoden eines Erysipels aufgetreten waren und zwischen November 1988 und November 1991 in die Abteilung für Infektionskrankheiten des Roslagstull Krankenhaus, Stockholm, Schweden, eingewiesen wurden, wurden in die Studie aufgenommen. Bei 20 Patienten, die die Prophylaxe erhielten und 20 Kontrollen wurde über einen mittleren Zeitraum von 15 Monaten eine Verlaufsstudie nach Life Table Analysis vorgenommen. Als tägliche Prophylaxe wurde Phenoxymethylpenicillin oder, bei Penicillinallergie, Erythromycin verordnet. Die tägliche Antibiotikaprophylaxe führte offensichtlich zu einer Reduktion der Erysipel-Rezidive, doch war der Effekt nicht sehr ausgeprägt (p=0,06). Eine kontinuierliche Antibiotika-prophylaxe ist somit nur bei Patienten mit hohem Erysipel-Rezidivrisiko indiziert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jorup-Rönström, C., Britton, S., Gavlevik, A., Gunnarsson, K., Redman A. C. The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 12 (1984) 390–394.

    Google Scholar 

  2. Jorup-Rönström, C. Epidemiological, bacteriological and complicating features of erysipelas. Scand. J. Infect. Dis. 18 (1986) 519–524.

    Google Scholar 

  3. Crickx, B., Chevron, F., Sigal-Nahum, M., Bilet, S., Fauche, F., Picar, C., Lazareth, I., Belaich, S. Erysipelas: epidemiological, clinical and therapeutic data. Ann. Dermatol. Venereol. 118 (1991) 11–16.

    Google Scholar 

  4. Hugo-Persson, M., Norlin, K. Erysipelas and group G streptococci. Infection 15 (1987) 184–187.

    Google Scholar 

  5. Jorup-Rönström, C., Britton, S. Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection 15 (1987) 105–106.

    Google Scholar 

  6. Ströberl, C. The importance of local factors in recurrent erysipelas. Z. Hautkr. 60 (1985) 712–723.

    Google Scholar 

  7. Norgren, L. Functional evaluation of chronic venous insufficiency by foot volumetry. Acta Chir. Scand. Suppl. 444 (1974) 12–16.

    Google Scholar 

  8. Kremer, M., Zuckerman, R., Avraham, Z., Raz, R. Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J. Infection 22 (1991) 37–40.

    Google Scholar 

  9. Ginsberg, M. Cellulitis: analysis of 101 cases and review of the literature. South. Med. J. 74 (1981) 530–533.

    Google Scholar 

  10. Witkowski, J., Parish, L. C. Bacterial skin infections. Cutaneous Infection 72 (1982) 166–185.

    Google Scholar 

  11. Ferrieri, P., Dajani, A. S., Wannamaker, L. W., Chapman, S. S. Natural history of impetigo Site sequence of acquisition and familial patterns spread of cutaneous streptococci. J. Clin. Invest. 51 (1972) 2851–2862.

    Google Scholar 

  12. Von Härtel, S., Gramatte, Th., Sholtz, A., Terhaag, B. Sulfamerazin-prophylaxis in chronical relapsing erysipelas. Dermatol. Monatsschr. 174 (1988) 485–492.

    Google Scholar 

  13. Duvanel, T., Mérot, Y., Harms, M., Saurat, J.-H. Prophylactic antibiotics in erysipelas. Lancet i (1985) 1401.

    Google Scholar 

  14. Bitnun, S. Prophylactic antibiotics in recurrent erysipelas. Lancet i (1985) 345.

    Google Scholar 

  15. Thind, P. Prophylactic antibiotics in recurrent erysipelas. Lancet i (1985) 986.

    Google Scholar 

  16. Keefer, C. S., Rantz, L. A., Shuman, H. H., Rammelkamp, Ch. Distribution of specific types of hemolytic streptococci in eight hundred and nineteen cases of infection. Arch. Intern. Med. 69 (1942) 952–973.

    Google Scholar 

  17. Anthony, B. F., Perlman, L. V., Wannamaker, L. W. Skin infections and acute nephritis in American Indian children. Pediatrics 39 (1967) 263–279.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sjöblom, AC., Eriksson, B., Jorup-Rönström, C. et al. Antibiotic prophylaxis in recurrent erysipelas. Infection 21, 390–393 (1993). https://doi.org/10.1007/BF01728920

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01728920

Keywords

Navigation